74 related articles for article (PubMed ID: 30027187)
21. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
[TBL] [Abstract][Full Text] [Related]
22. Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems.
Sanna D; Ugone V; Micera G; Pivetta T; Valletta E; Garribba E
Inorg Chem; 2015 Sep; 54(17):8237-50. PubMed ID: 26280599
[TBL] [Abstract][Full Text] [Related]
23. Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Jung Y; Shin SY; Yong Y; Jung H; Ahn S; Lee YH; Lim Y
Chem Biol Drug Des; 2015 May; 85(5):574-85. PubMed ID: 25298094
[TBL] [Abstract][Full Text] [Related]
24. Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells.
Sasai K; Katayama H; Stenoien DL; Fujii S; Honda R; Kimura M; Okano Y; Tatsuka M; Suzuki F; Nigg EA; Earnshaw WC; Brinkley WR; Sen S
Cell Motil Cytoskeleton; 2004 Dec; 59(4):249-63. PubMed ID: 15499654
[TBL] [Abstract][Full Text] [Related]
25. Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.
Sanna D; Serra M; Ugone V; Manca L; Pirastru M; Buglyó P; Bíró L; Micera G; Garribba E
Metallomics; 2016 May; 8(5):532-41. PubMed ID: 27121101
[TBL] [Abstract][Full Text] [Related]
26. Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny.
Wiedemuth R; Klink B; Fujiwara M; Schröck E; Tatsuka M; Schackert G; Temme A
Carcinogenesis; 2016 Oct; 37(10):993-1003. PubMed ID: 27515963
[TBL] [Abstract][Full Text] [Related]
27. Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression.
Heo SK; Noh EK; Jeong YK; Ju LJ; Sung JY; Yu HM; Cheon J; Koh S; Min YJ; Choi Y; Jo JC
Tumour Biol; 2019 May; 41(5):1010428319848612. PubMed ID: 31074363
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines.
Sak A; Stuschke M; Groneberg M; Kübler D; Pöttgen C; Eberhardt WE
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):492-9. PubMed ID: 22381900
[TBL] [Abstract][Full Text] [Related]
30. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
[TBL] [Abstract][Full Text] [Related]
31. Aurora B kinase is required for cytokinesis through effecting spindle structure.
Wu Q; Zhang W; Mu T; Song T; Li D
Cell Biol Int; 2013 May; 37(5):436-42. PubMed ID: 23584797
[TBL] [Abstract][Full Text] [Related]
32. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation.
Bolton MA; Lan W; Powers SE; McCleland ML; Kuang J; Stukenberg PT
Mol Biol Cell; 2002 Sep; 13(9):3064-77. PubMed ID: 12221116
[TBL] [Abstract][Full Text] [Related]
33. AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.
Kalous O; Conklin D; Desai AJ; Dering J; Goldstein J; Ginther C; Anderson L; Lu M; Kolarova T; Eckardt MA; Langerød A; Børresen-Dale AL; Slamon DJ; Finn RS
Breast Cancer Res Treat; 2013 Oct; 141(3):397-408. PubMed ID: 24091768
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle-dependent regulation of Aurora kinase B mRNA by the Microprocessor complex.
Jung E; Seong Y; Seo JH; Kwon YS; Song H
Biochem Biophys Res Commun; 2014 Mar; 446(1):241-7. PubMed ID: 24589731
[TBL] [Abstract][Full Text] [Related]
35. Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle.
Le LT; Couvet M; Favier B; Coll JL; Nguyen CH; Molla A
Oncotarget; 2015 Sep; 6(26):22152-66. PubMed ID: 26247630
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Aurora kinase B is important for biologic activity of the dual inhibitors of BCR-ABL and Aurora kinases R763/AS703569 and PHA-739358 in BCR-ABL transformed cells.
Illert AL; Seitz AK; Rummelt C; Kreutmair S; Engh RA; Goodstal S; Peschel C; Duyster J; von Bubnoff N
PLoS One; 2014; 9(11):e112318. PubMed ID: 25426931
[TBL] [Abstract][Full Text] [Related]
37. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
[TBL] [Abstract][Full Text] [Related]
38. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
Qi W; Liu X; Cooke LS; Persky DO; Miller TP; Squires M; Mahadevan D
Int J Cancer; 2012 Jun; 130(12):2997-3005. PubMed ID: 21796626
[TBL] [Abstract][Full Text] [Related]
39. The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells.
Xie F; Lang Q; Zhou M; Zhang H; Zhang Z; Zhang Y; Wan B; Huang Q; Yu L
Eur J Pharm Sci; 2012 Aug; 46(5):388-96. PubMed ID: 22449725
[TBL] [Abstract][Full Text] [Related]
40. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells.
Carvalho A; Carmena M; Sambade C; Earnshaw WC; Wheatley SP
J Cell Sci; 2003 Jul; 116(Pt 14):2987-98. PubMed ID: 12783991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
